Louisville Cooperative Tissue Biorepository (LCTB)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02021916 |
Recruitment Status : Unknown
Verified December 2013 by Robert C. Martin, University of Louisville.
Recruitment status was: Recruiting
First Posted : December 27, 2013
Last Update Posted : December 27, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Normal and Abnormal Tissue |
Study Type : | Observational |
Estimated Enrollment : | 5000 participants |
Observational Model: | Case-Only |
Time Perspective: | Cross-Sectional |
Official Title: | Louisville Cooperative Tissue Biorepository of the James Graham Brown Cancer Center Tissue Collection Consent |
Study Start Date : | July 2005 |
Estimated Primary Completion Date : | January 2020 |
- Collect normal and abnormal tissues that are removed from the human body as a part of standard surgical practice after adequate portions are secured by surgical pathologists to allow for correct diagnoses to be made. [ Time Frame: 15 Years ]
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 7 Years and older (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patients undergoing surgery for removal or normal and abnormal tissues as part of standard medical and surgical practice
Exclusion Criteria:
- Patients with known systematic infections including septic patients with bacterial and viral infections, hepatitis, HIV, TB and other defined pathogens will not be included.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02021916
Contact: Robert Martin, M.D., Ph.D. | 502-629-3355 | robert.martin@louisville.edu |
United States, Kentucky | |
University of Louisville | Recruiting |
Louisville, Kentucky, United States, 40202 | |
Contact: Robert Martin, M.D., Ph.D. 502-629-3355 robert.martin@louisville.edu | |
Principal Investigator: Robert Martin, M.D., Ph.D. |
Principal Investigator: | Robert Martin, MD, PhD | University of Louisville |
Responsible Party: | Robert C. Martin, Professor, University of Louisville |
ClinicalTrials.gov Identifier: | NCT02021916 |
Other Study ID Numbers: |
397.05 |
First Posted: | December 27, 2013 Key Record Dates |
Last Update Posted: | December 27, 2013 |
Last Verified: | December 2013 |